Related Experiment Video
Updated: Jul 13, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Cadaver fitting study of the DexAide right ventricular assist device
Yoshio Ootaki1, Chiyo Ootaki, Keiji Kamohara
1Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Artificial Organs
|July 27, 2007
Summary
This study evaluated the DexAide right ventricular assist device (RVAD) for optimal cannula design and implantation. Right thoracic implantation demonstrated an excellent anatomical fit, preparing the RVAD for clinical use.
Area of Science:
- Medical Devices
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- The DexAide right ventricular assist device (RVAD) offers an implantable solution for surgeons.
- Pre-clinical evaluation is crucial for optimizing device performance and patient outcomes.
Purpose of the Study:
- To determine the optimal cannula design for the DexAide RVAD.
- To identify the ideal implantation location for the DexAide RVAD.
- To assess the anatomical compatibility of the DexAide RVAD with existing left ventricular assist devices (LVADs).
Main Methods:
- Utilized five preserved human cadavers for anatomical assessment.
- Implanted HeartMate XVE and CorAide LVAD models into preperitoneal and right thoracic spaces.
- Evaluated the anatomical fit of the DexAide RVAD, including inflow cannula insertion into the right ventricle and outflow to the pulmonary artery.
Main Results:
- Right thoracic implantation of the DexAide RVAD achieved an excellent anatomical fit in all cadavers.
- The device demonstrated compatibility when implanted alongside both HeartMate and CorAide LVAD models.
- Successful placement of the inflow cannula through the right ventricle's diaphragmatic surface was confirmed.
Conclusions:
- The right thoracic implantation site is suitable for the DexAide RVAD.
- Findings support the optimization of cannula design and implantation strategies for future clinical applications.
- This research provides essential data for the successful clinical integration of the DexAide RVAD.
